Table:
begin	end	state
1	17	cytoplasmic
18	39	transmembrane
40	47	non-cytoplasmic
48	69	transmembrane
70	89	cytoplasmic
90	112	transmembrane
113	125	non-cytoplasmic
126	145	transmembrane
146	152	cytoplasmic
153	175	transmembrane
176	194	non-cytoplasmic
195	213	transmembrane
214	232	cytoplasmic
233	254	transmembrane
255	278	non-cytoplasmic
279	310	transmembrane
311	330	cytoplasmic
331	351	transmembrane
352	356	non-cytoplasmic
357	375	transmembrane
376	386	cytoplasmic
387	406	transmembrane
407	411	non-cytoplasmic
412	429	transmembrane
430	443	cytoplasmic

Input:
>PP_2802 FitnessBrowser__Putida:PP_2802
MSQSTSGASLRRSLGPFSVLLFGLAFLAPLIVFGTYGVITQASGNTTAMAYLVAATGVVF
TALSYGRLVRVFPVAGSAYTYTRKMLNANLGFMVGWAALLDYFFIPMLIWLLGASYLNMA
FPEVPQWVWITGFIVSTSLLNVLGIQVANRFNVLLMVVQLVIIAVFIGLCVHYIVAANGP
GGLLSAKPFFNQDVPFATSMAGAAIAAYSFLGFDALSTLSEETRDPGRTLPRAILLVALI
GGSVYVGSSYFMYLAHPSPTFELVDGAAFEIARMIGGDLFFAVVLTGIIVAHFAAGMSFQ
ASVGRLLYALGRDNQLPRRLFGALHPRYKTPAFNILLCGVFGTAGFGLTIATATSLVNFG
AFLAFTAVNLCALRLTFDARVKDGAGLLRGVLFPLIGLVTAGWMLVSLDKDALIMGGCWL
GLGLVYLACRTSLFRNPVPDALV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server